Numerous Asian countries have a high prevalence of metabolic syndrome, also associated with cardiovascular disease and diabetes mellitus. Healthcare expenditure varies among Asian countries, and is influenced by poverty factor and large populations. The effect of metabolic syndrome on nutritional management in Asia demonstrates the essential for clinicians to equalize the needs for higher standards of dietetics practice; as they execute optimal care processes with the aim of improving outcomes, alongside setting of workforce limitations, inadequate expertise in metabolic syndrome nutrition practice, as well as ethnic diversity among Asians. This paper presents some aspects of dietetics practice and the possibility that an alteration in practice is mandatory if dietitians are to play an active role in preventing or decelerating the evolution of the metabolic syndrome.
1. Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr 83: 1248-1251, 2006.
2. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289-2304, 2005.
3. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005.
5. Wu A, Kong N, de Leon F et al. An alarmingly high prevalence of diabetes nephropathy in Asian type 2 diabetic patients: the microalbuminuria prevalence (MAP) study. Diabetologia 48: 1674-1675, 2005.
6. Kong A, So W, Szeto C et al. Assessment of glomerular filtration rate in addition to albuminuria I important in managing type II diabetes. Kidney Int 69: 383-387, 2006.
7. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27: 1182-1186, 2004.
8. Gu D, Reynolds K & Wu X, Chen J, Duan X, Reynolds RF et al. InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365: 1398-1405, 2005.
9. Alberti K, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet 366: 1059-1062, 2005.
10. Urakami T, Kubota S, Nitadori Y, Harada K, Owada M, Kitagawa T. Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 28: 1876-1881, 2005.
11. Wei J, Sung F, Lin C, Lin R, Chiang C, Chuang L. National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA 290: 1345-1350, 2003.
12. Szapary PO, Hark LA, Burke FM. The metabolic syndrome: A new focus for lifestyle modification. Patient Care 36: 75-88, 2002.
18. Deen D. Metabolic syndrome: Time for action. Am Fam Physician 69: 2875-2882, 2004.
19. Grundy SM. Metabolic syndrome: A multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92: 399-404, 2007.
20. Lichtenstein AH, Appel LJ, Brands M et al. Diet and lifestyle recommendations revision 2006. A scientific statement from the American Heart Association Nutrition Committee. Circulation 114: 82-96, 2006.
21. Riccardi G, Rivellese AA. Dietary treatment of the metabolic syndrome- the optimal diet. Br J Nutr 83(Suppl 1): S143-S148, 2000.
23. Chan JC, So WY, Yeung CY et al. Effects of structured versus usual care on renal endpoint in type 2 diabetes. The SURE study: a randomized multicenter translational study. Diabetes Care 32: 977-982, 2009.